Close
ACHEMA MIDDLE EAST 2026

Lilly to Build $3B Manufacturing Facility in Netherlands

Eli Lilly and Company is investing $3 billion to build a new manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park....

AstraZeneca Secures EU Approval for Koselugo to Treat NF1 PN

Alexion, an AstraZeneca rare disease, has received EU approval for Koselugo (selumetinib), its oral, selective MEK inhibitor, to treat symptomatic, inoperable plexiform neurofibromas (PN)...

UK Grants Pharma Firms Early Access to Aligned Pathway

Pharmaceutical companies producing qualifying medicines can now benefit from an accelerated approvals pathway, gaining access significantly earlier than initially expected. The Medicines and Healthcare products...

ABPI Launches Manifesto to Advance Scottish Pharma Sector

The Association of the British Pharmaceutical Industry (ABPI) has released its manifesto for the Scottish Government, calling for political leaders to act now and...

Pharmaceutical Tariff Agreed at 15% Under US-EU Trade Deal

Pharmaceutical tariffs between the European Union and the United States will now be limited at 15% under the terms of the latest trade agreement,...

Lupin, Sandoz Collab to Commercialise Biosimilar Ranibizumab

Lupin partners with Sandoz Group AG to commercialise and market its biosimilar ranibizumab worldwide. The product will be commercialised in a number of markets,...

Pharmaceutical Chemicals Market Booms with Rising API Demand

The international pharmaceutical chemicals market is witnessing vibrant growth, driven by expanding demand for Active Pharmaceutical Ingredients (APIs) and specialty chemical innovations. The expression...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...